Health
UCLH doses first patient in the world in Covid-19 antibody trial – University College London Hospitals
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
Researchers in the STORM CHASER study led by UCLH virologist Dr Catherine Houlihan recruited the first participant in the world to the study earlier this month and have recruited 10 participants to date.
They believe the antibody or LAAB, known as AZD7442 and developed by AstraZeneca, may offer immediate and long-term protection to people who have…
-
Noosa News14 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
Noosa News23 hours agoE-Scooter accident | Noosa Today
-
Business15 hours ago3 ASX ETFs that could be perfect for beginners
-
General22 hours agoOutback Farm stars finish first barley harvest at Central Australian farm